MLSSMilestone Scientific Inc.

AMEX · US · Healthcare · Medical Instruments & Supplies · milestonescientific.com

0.4808USD+2.28%Mkt Cap: 42.67M $P/E: —3d ago

Milestone Scientific Inc., a biomedical technology company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical and dental use in the United States, C…

Industry Peers

Medical Instruments & Supplies

Screen all

ISRG

Intuitive Surgical, Inc.

$135.72BUSDP/E 43.4

EssilorLuxottica Societe anonyme

$81.53BUSDP/E 30.5

BDX

Becton, Dickinson and Company

$52.30BUSDP/E 33.2

MDLN

Medline Inc. Class A Common Stock

West Pharmaceutical Services, Inc.

$24.85BUSDP/E 45.2

DIM

Sartorius Stedim Biotech

$20.46BUSDP/E 64.5

SRT3

Sartorius Aktiengesellschaft

Sartorius Aktiengesellschaft

$14.73BUSDP/E 69.1

SOLV

Solventum Corporation Common Stock

$15.25BUSDP/E 10.9

COO

The Cooper Companies, Inc.

$14.87BUSDP/E 64.6

BAX

Baxter International Inc.

$13.62BUSD

ALGN

Align Technology, Inc.

Key Statistics

Company

Market Cap42.67M $

Enterprise Value41.21M $

Revenue (TTM)9.42M $

Gross Profit6.41M $

Net Income (TTM)-5.72M $

Revenue/Share0.1110 USD

Last Price0.4808 USD

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees15

CountryUS

SectorHealthcare

IndustryMedical Instruments & Supplies

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)-13.74

PEG—

EV/EBITDA-10.24

EV/Revenue4.37

P/S4.53

P/B17.17

EPS (TTM)-0.05

EPS (Forward)-0.04

52W Range

0.220057% of range0.6800

52W High0.6800 USD

52W Low0.2200 USD

Profitability

Gross Margin71.40%

Oper. Margin-37.36%

EBITDA Margin-42.73%

Profit Margin-63.76%

ROE-203.45%

ROA-73.30%

Growth

Revenue Growth22.30%

Earnings Growth—

Cash Flow & Leverage

Operating CF-2.92M $

CapEx (TTM)15.12K $

FCF Margin10.42%

FCF Yield2.30%

Net Debt-1.45M $

Net Debt/EBITDA0.36

Balance Sheet

Debt/Equity0.36

Current Ratio1.85

Quick Ratio0.71

Book Value/Sh0.0280 USD

Cash/Share0.0230 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Splits

Last Split1:3

Split DateJan 14, 2004

Analyst Consensus

Rating1.5 (Buy)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)1.250 USD

Upside (mean)+160.0%

Target Range1.000 USD – 1.500 USD

$1.000+160.0% to mean$1.500

# Analysts2

Ownership

Shares Out.88.74M

Float71.29M

Insiders16.01%

Institutions5.30%

Short Interest

Short Ratio1.0d

Short % Float0.16%

Short % Out.0.13%

Shares Short113.46K

Short (prev mo.)262.59K

Technical

SMA 500.4036 (+19.1%)

SMA 2000.3380 (+42.2%)

Beta1.05

S&P 52W Chg19.18%

Avg Vol (30d)170.87K

Avg Vol (10d)245.17K

Technical Indicators

RSI (14)56.3

MACD0.0280

MACD Signal0.0287

MACD Hist.-0.0006

BB Upper0.5513 USD

BB Middle0.4537 USD

BB Lower0.3561 USD

BB Width43.04%

ATR (14)0.0402 USD

Vol Ratio (20d)0.43x